Adam Miller, MD
Foot and Ankle Surgery · Cincinnati, OHNPI 1831366897
Payments from drug & device makers
Across 54 payments — averaging $234.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ortho Solutions Inc$6K
- Legacy Ortho LLC$4K
- Stryker$878
- Johnson & Johnson$211
- Arthrex$209
- Onkos Surgical, Inc.$153
- plus $939 from 13 others
What the payments were for
- Royalty or licence$5,67545%
- Travel & lodging$6725%
- Food & beverage$2,15017%
- Education$4,17833%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ortho Solutions Inc | 9 | $6,083 |
| Legacy Ortho LLC | 6 | $4,202 |
| Stryker(2 entities) | 6 | $878 |
| Johnson & Johnson | 2 | $211 |
| Arthrex | 3 | $209 |
| Onkos Surgical, Inc. | 1 | $153 |
| Bioventus LLC | 1 | $147 |
| Orthofix Medical, Inc. | 3 | $143 |
| Biotissue Holdings Inc. | 1 | $125 |
| Integra Lifesciences Corporation | 7 | $114 |
| Intersect ENT, Inc. | 1 | $76 |
| Medtronic | 1 | $74 |
| Smith+Nephew | 3 | $61 |
| Zimmer Biomet | 2 | $60 |
| Merck | 2 | $49 |
| Ferring Pharmaceuticals Inc. | 2 | $31 |
| Gilead | 2 | $27 |
| Pacira Pharmaceuticals Incorporated | 1 | $20 |
| Ultragenyx Pharmaceutical Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY$578
- TrueLok$226
- DYNACORD$211
- HEALIX KNOTLESS PEEK$211
- TRUESPAN ORTHOCORD$211
- ELEOS LIMB SALVAGE SYSTEM$153
- Exogen Ultrasound Bone Healing System$147
- CARTIVA$125
- CLARIX$125
- ORTHOLOC 3DI CROSSCHECK$119
- Gryphon Orthocord$111
- COR$111
- NA$100
How this compares
$12,676 in reported general payments places this provider in the 80th percentile of 429 foot and ankle surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enoxaparin Sodium | 52 | $6,166 |
| Hydroxyzine Pamoate | 52 | $280 |
| Diclofenac Sodium | 14 | $211 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $174 |
| Ondansetron Hcl | 49 | $122 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 18 | $103 |
| Meloxicam | 12 | $23 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Cincinnati
- Robert BrarensCincinnati$108K
- Chad MillerCincinnati$31K
- Timothy WylieCincinnati$22K
- Christopher HyerWorthington$4.9M
- Thomas LeePickerington$4M
- Jordan GrossmanAkron$2.5M
- Robert GorslineHilliard$1.4M
- Jonathan FeibelGahanna$1.4M
- Mark PrisselWorthington$1.3M
- Windy ColeKent$889K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.